<DOC>
	<DOCNO>NCT02257151</DOCNO>
	<brief_summary>The purpose study evaluate safety , pharmacokinetics , target engagement BMS-986142 healthy subject .</brief_summary>
	<brief_title>Study Evaluate Safety , Pharmacokinetics Target Engagement BMS-986142 Healthy Subjects</brief_title>
	<detailed_description>Allocation : Randomized Controlled Trial ( SAD/MAD ) Masking : Double-Blind ( SAD/MAD )</detailed_description>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com 1 . Healthy male female subject determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination 2 . Body Mass Index ( BMI ) 18 32 kg/m2 , inclusive . BMI=weight ( kg ) / [ height ( ) ] 2 1 . Any significant acute chronic medical illness 2 . Current recent ( within 3 month study drug administration ) gastrointestinal disease 3 . Any major surgery within 4 week study drug administration 4 . Any gastrointestinal surgery could impact upon absorption study drug 5 . Donation blood blood bank clinical study ( except screen visit ) within 4 week study drug administration ( within 2 week plasma )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Volunteers</keyword>
</DOC>